false
0001554818
0001554818
2025-08-22
2025-08-22
0001554818
us-gaap:CommonStockMember
2025-08-22
2025-08-22
0001554818
AUUD:CommonStockWarrantsMember
2025-08-22
2025-08-22
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
August 22, 2025 (August 22, 2025)
AUDDIA
INC.
(Exact name of registrant as specified
in its charter)
| Delaware |
|
001-40071 |
|
45-4257218 |
|
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(I.R.S. Employer
Identification No.) |
| 1680
38th Street, Suite
130 |
|
|
| Boulder, Colorado |
|
80301 |
| (Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (303) 219-9771
Not Applicable
Former name or former address, if changed since
last report
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of exchange on which registered |
| Common Stock |
AUUD |
Nasdaq Stock Market |
| Common Stock Warrants |
AUUDW |
Nasdaq Stock Market |
Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Item 1.01. |
Entry into a Material Definitive Agreement. |
On August 22, 2025, Auddia
Inc. (the “Company”) entered into an At-the-Market Issuance Sales Agreement (the “Sales Agreement”)
with Ascendiant Capital Markets, LLC, as sales agent (the “Agent”), to sell shares of its common stock, par value $0.001
per share (the “Common Stock”), having an aggregate offering price of up to $10,000,000 (the “Shares”)
from time to time, through an “at the market offering” (the “ATM Offering”) as defined in Rule 415 under
the Securities Act of 1933, as amended (the “Securities Act”). The aggregate market value of shares of its Common Stock
eligible for sale under the Sales Agreement will be subject to the limitations of General Instruction I.B.6 of Form S-3, to the extent
required under such instruction. On August 22, 2025, the Company filed a prospectus supplement with the Securities and Exchange Commission
(“SEC”) relating to the offer and sale of up to $3,042,500 of shares of its Common Stock in the ATM Offering, which
is based on the limitations of General Instruction I.B.6 of Form S-3.
The offer and sale of
the Shares will be made pursuant to the Company’s effective “shelf” registration statement on Form S-3 and an accompanying
base prospectus contained therein (Registration Statement No. 333-288185) filed with the SEC on June 24, 2025, and declared effective
by the SEC on June 27, 2025.
This Current Report on
Form 8-K shall not constitute an offer to sell or the solicitation of any offer to buy the Shares, nor shall there be any offer, solicitation
or sale of the Shares in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of such state.
Subject to the terms
and conditions of the Sales Agreement, the Agent will use its commercially reasonable efforts to sell the Shares, based upon the Company’s
instructions, consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and
rules of the Nasdaq Stock Market. The Company will set the parameters for sales of the Shares, including the number of Shares to be sold,
the time period during which sales are requested to be made, any limitation on the number of Shares that may be sold in one trading day,
and any minimum price below which sales may not be made. Under the Sales Agreement, the Agent may sell the Shares by any method permitted
by law deemed to be an “at the market offering,” as defined in Rule 415 of the Securities Act. The Company or the Agent may,
upon written notice to the other party in accordance with the terms of the Sales Agreement, suspend offers and sales of the Shares.
The Company will pay
the Agent a commission of up to 3.0% of the gross proceeds from the sales of Shares sold through the Agent under the Sales Agreement and
has provided the Agent with customary indemnification and contribution rights. The Company will also reimburse the Agent for certain expenses
incurred in connection with the Sales Agreement.
The Company is not obligated
to make any sales of Shares under the Sales Agreement. The Company and the Agent each have the right, in its sole discretion, to terminate
the Sales Agreement pursuant to the terms and subject to the conditions set forth in the Sales Agreement.
The foregoing description
of the Sales Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Sales Agreement
which is attached hereto as Exhibit 1.1.
A copy of the opinion
of Carroll Legal LLC relating to the validity of the shares of common stock that may be sold pursuant to the Sales Agreement is filed
herewith as Exhibit 5.1.
| Item 9.01. |
Financial Statements and Exhibits. |
(d) Exhibits. The following exhibits are filed with this Form 8-K:
| Exhibit Number |
|
Description |
| 1.1 |
|
At-The-Market Issuance Sales Agreement, dated August 22, 2025, by and between Auddia Inc. and Ascendiant Capital Markets, LLC. |
5.1 |
|
Opinion of Carroll Legal LLC. |
| 23.1 |
|
Consent of Carroll Legal LLC (included in Exhibit 5.1). |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
| |
AUDDIA INC. |
| |
|
|
August 22, 2025 |
By: |
/s/ John E. Mahoney |
| |
|
Name: John E. Mahoney |
| |
|
Title: Chief Financial Officer |